IRVINE, Calif., CombiMatrix Corporation, a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that one of the nation’s leading clinicians in the field of reproductive genetics has called for chromosomal microarray testing to replace karyotyping, the historic practice, as the standard of care for prenatal testing. CombiMatrix is one […]
CHATSWORTH, Calif., IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of high-value personalized diagnostics tests, today announced that its Sample Processing division has signed an agreement with Fisher HealthCare, part of Thermo Fisher Scientific Inc. (NYSE:TMO), as its first commercial distribution partner for the new ThermoBrite […]
MILFORD, Mass., SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses […]
CAMBRIDGE, MA, Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today that it will apply its cutting-edge technology towards the development of an improved test to aid in the diagnosis of active tuberculosis (TB). In collaboration with the Forsyth Institute and […]
SAN DIEGO, Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced that its wholly-owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has expanded the application of its recently launched laboratory-developed test (LDT). The Company also announced it has rebranded the test under the name MaterniT21 PLUS, which includes the […]
LEXINGTON, Mass., T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled “NMR Device for Detection of Analytes”. The patent broadly covers devices and methods of detecting analytes through magnetic resonance measurement, the basis for T2 Bio’s […]
CARLSBAD, Calif. — Life Technologies Corporation today announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as President, Medical Sciences. Andrews has more than 25 years of experience in the diagnostics industry, including leadership positions at companies such as Abbott Diagnostics and Roche Diagnostics. As President, […]
SAN DIEGO, Sequenom, Inc. today announced that a new publication of an independent multi-center study on Sequenom Center for Molecular Medicine’s MaterniT21™ laboratory-developed test (LDT) appears today in the online issue of Genetics in Medicine. The study demonstrated the LDT can detect fetal trisomy 21, 18 and 13 with high accuracy from a maternal blood […]
PLEASANTON, Calif. — Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collected vaginal swabs. A polymerase chain reaction (PCR)-based multiplex […]
WALTHAM, Mass.–Thermo Fisher Scientific, the world leader in serving science, today announced an agreement with global healthcare provider Abbott Laboratories to make its Procalcitonin (PCT) assay available with Abbott’s immunochemistry analyzers. The company’s Thermo Scientific B.R.A.H.M.S Procalcitonin (PCT) assay will be available on Abbott’s ARCHITECT® “i” and “ci” series of immunochemistry analyzers. Abbott’s high-, medium-, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
